about
A review of preclinical safety data for magnevist (gadopentetate dimeglumine) in the context of nephrogenic systemic fibrosis.Azelaic acid: Properties and mode of action.Gadolinium-based contrast agents and NSF: evidence from animal experience.Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents: Comparison of Linear and Macrocyclic Agents.Comments on the article "Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS)" by Tomohiro Sato, Tsutomu Tamada, Shigeru Watanabe et al. DOI 10.1007Contrast Media for X-ray and Magnetic Resonance Imaging: Development, Current Status and Future Perspectives.The role of residual gadolinium in the induction of nephrogenic systemic fibrosis-like skin lesions in rats.The impact of the viscosity and osmolality of iodine contrast agents on renal elimination.Impact of renal impairment on long-term retention of gadolinium in the rodent skin following the administration of gadolinium-based contrast agents.Multidetector computed tomography (MDCT) evaluation of myocardial viability: intraindividual comparison of monomeric vs. dimeric contrast media in a rabbit model.Lbx1 acts as a selector gene in the fate determination of somatosensory and viscerosensory relay neurons in the hindbrain.The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety.Viscosity of iodinated contrast agents during renal excretion.Efficacy and safety of lanthanoids as X-ray contrast agents.Long-term retention of gadolinium in the skin of rodents following the administration of gadolinium-based contrast agents.The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis - a mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamideResponse to Editorial: Animal Models for Nephrogenic Systemic FibrosisThe bHLH transcription factor Olig3 marks the dorsal neuroepithelium of the hindbrain and is essential for the development of brainstem nuclei
P50
Q33636401-B268CBA2-0F65-4A55-AEDD-C135E1C3BD46Q34388183-97CEFAE5-717E-4F7D-855A-0973633B0442Q37638618-242FFE4F-5E90-4768-BA5A-9A232137322FQ38327912-026E83DA-EA1D-4C90-8193-37AD005C651AQ38415368-1DB1AABD-A995-429E-B3A7-20C8CCE9A704Q38553543-69D4B9B4-8E68-4D03-BE3D-D4A9B4BBC15BQ42861934-AFE90D45-7D0C-4D9A-BEEB-D8ADF318BC01Q43106606-C11947F8-67B4-4D05-ADF2-D5E0E4C95AEDQ46104324-22D4F3D0-6891-45E5-8B10-0198ABA42EA2Q46408631-142D7298-6E79-4903-B376-D25D94EA33A5Q48180695-AA87BF0D-E179-4230-9E71-5C89E9F1F678Q52887336-D1CBFA19-19D5-4278-BA23-3C731B1A5A4FQ52897550-D22155B4-F4BB-4101-850B-91D038D95524Q52906709-24BDC0E3-62F1-468D-8D1D-5FC477E76B61Q52913160-936C68CE-ACF8-4D66-82D9-19D55DC507C6Q57185976-4411544B-AE5F-415C-A2AA-816E6E6DFB23Q58186563-9CB5D3E5-2ACE-4FE9-9922-EAE5651B1DCBQ59205638-B92AA84E-0260-42AC-8901-8FEC65C20BDD
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Martin A Sieber
@en
Martin A Sieber
@nl
type
label
Martin A Sieber
@en
Martin A Sieber
@nl
prefLabel
Martin A Sieber
@en
Martin A Sieber
@nl
P31
P496
0000-0002-6098-5564